PT94575A - Processo para a preparacao de novas citoquinas - Google Patents

Processo para a preparacao de novas citoquinas

Info

Publication number
PT94575A
PT94575A PT94575A PT9457590A PT94575A PT 94575 A PT94575 A PT 94575A PT 94575 A PT94575 A PT 94575A PT 9457590 A PT9457590 A PT 9457590A PT 94575 A PT94575 A PT 94575A
Authority
PT
Portugal
Prior art keywords
derivatives
polypeptides
preparation
mediators
cytokins
Prior art date
Application number
PT94575A
Other languages
English (en)
Other versions
PT94575B (pt
Inventor
Karel Gerrit Odink
Josef Brueggen
Walter Wiesendanger
Nico Cerletti
Lajos Tarcsay
Clemens Sorg
Christiane Dewolf-Peeters
Jan Delabie
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT94575A publication Critical patent/PT94575A/pt
Publication of PT94575B publication Critical patent/PT94575B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Transmission Device (AREA)
  • Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT94575A 1989-07-05 1990-07-03 Processo para a preparacao de novas citoquinas PT94575B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898915414A GB8915414D0 (en) 1989-07-05 1989-07-05 Novel cytokines

Publications (2)

Publication Number Publication Date
PT94575A true PT94575A (pt) 1991-03-20
PT94575B PT94575B (pt) 1997-02-28

Family

ID=10659582

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94575A PT94575B (pt) 1989-07-05 1990-07-03 Processo para a preparacao de novas citoquinas

Country Status (14)

Country Link
US (2) US5411882A (pt)
EP (1) EP0412050B1 (pt)
JP (1) JPH0356499A (pt)
AT (1) ATE131873T1 (pt)
AU (1) AU649226B2 (pt)
CA (1) CA2020303A1 (pt)
DD (1) DD298948A5 (pt)
DE (1) DE69024279T2 (pt)
DK (1) DK0412050T3 (pt)
ES (1) ES2081960T3 (pt)
GB (1) GB8915414D0 (pt)
GR (1) GR3018521T3 (pt)
IE (1) IE70519B1 (pt)
PT (1) PT94575B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263072B1 (en) * 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
ES2252732T3 (es) 1992-05-26 2006-05-16 Immunex Corporation Nueva citoquina que une cd30.
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2005021546A1 (en) 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US20080299128A1 (en) * 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
US8329186B2 (en) * 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
CA2620626C (en) 2004-12-20 2011-06-07 Isu Abxis Co., Ltd. Molecules inhibiting intercellular adhesion
US7740856B2 (en) * 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
CA2600175A1 (en) 2005-03-24 2006-03-20 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
MXPA05011139A (es) * 2005-10-17 2007-04-17 Concretos Translucidos S De R Formulacion para obtener una mezcla de concreto conductivo.
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US9249217B2 (en) * 2010-12-03 2016-02-02 Secretary, DHHS Bispecific EGFRvIII x CD3 antibody engaging molecules
WO2013050453A1 (en) 2011-10-07 2013-04-11 Baxter Healthcare S.A. Oxmif as a diagnostic marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672158B2 (ja) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
EP0263072B1 (en) * 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
DE3855802T2 (de) * 1987-10-02 1997-06-12 The Rockefeller University, New York, N.Y. Von Makrophagen abstammender Entzündungsvermittler(MIP-1-alpha et MIP-1-beta)

Also Published As

Publication number Publication date
ES2081960T3 (es) 1996-03-16
IE70519B1 (en) 1996-12-11
PT94575B (pt) 1997-02-28
JPH0356499A (ja) 1991-03-12
GB8915414D0 (en) 1989-08-23
DK0412050T3 (da) 1996-01-29
CA2020303A1 (en) 1991-01-06
GR3018521T3 (en) 1996-03-31
IE902426A1 (en) 1991-06-19
AU649226B2 (en) 1994-05-19
EP0412050B1 (en) 1995-12-20
DE69024279D1 (de) 1996-02-01
DE69024279T2 (de) 1996-10-17
DD298948A5 (de) 1992-03-19
ATE131873T1 (de) 1996-01-15
US5411882A (en) 1995-05-02
US5821336A (en) 1998-10-13
AU5809590A (en) 1991-01-10
EP0412050A1 (en) 1991-02-06

Similar Documents

Publication Publication Date Title
PT94575A (pt) Processo para a preparacao de novas citoquinas
CA2047717A1 (en) Monoclonal antibodies for small moieties, methods therefor
PT868519E (pt) Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
WO1991006866A3 (en) Urinary tumor associated antigen, antigenic subunits uses and methods of detection
ES2057476T3 (es) Medios para el diagnostico de neuropatias desmielinizantes, en particular de la esclerosis en placas.
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ES2131066T3 (es) Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
EP0585960A3 (en) Diagnostic method for autoimmune diseases
ES542864A0 (es) Aparato para la criofijacion de especimenes.
DK592086A (da) Humant conglutinin
CA2062820A1 (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
IT1159983B (it) Composizione polimera vulcanizzabile procedimento per la sua preparazione e vulcanizzato ottenuto mediante rascaldamento di tale composizione
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
DE69024814D1 (de) Verfahren zur verbesserten herstellung von menschlichen antikörpern sowie hierzu benutzte zellen
FI893009A (fi) Yttre fastsaettningsanordning.
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
SE8704485D0 (sv) Forfarande och anordning for beredning av en suspension for metning
ATE78513T1 (de) Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression.
SE7904276L (sv) Renat cancerassocierat protein
NO180637C (no) Fremgangsmåte for fremstilling av monoklonale antistoffer eller fragmenter derav
ES2056834T3 (es) Peptido con propiedades antigenicas aislado del grupo de proteinas 28 kd de s. mansoni y su procedimiento de separacion, anticuerpos monoclonales que reconocen al menos un epitopo de dicho peptido, asi como aplicaciones de este para la sintesis de anticuerpos neutralizantes.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19900927

FG3A Patent granted, date of granting

Effective date: 19961127

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000531